Guillermo Villacampa

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Guillermo Villacampa
Feb 21, 2025, 10:00 | Blog
Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared a paper he and his…
Dec 24, 2024, 13:29 | Science
Francesco Schettini: Which ADC is to prioritise in HR+ and TN BC?
Francesco Schettini, Medical Oncologist at the Breast Unit of the Hospital Clinic of Barcelona and…
Oct 29, 2024, 13:05 | Insight
Paolo Tarantino: My 100th scientific publication
Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "It turns out…
Oct 20, 2024, 13:14 | Insight
Tomás Pascual: Systematic review and meta-analysis of ADCs and ICIs in solid tumors
Tomás Pascual, Medical oncologist in Breast Cancer at Hospital Clinic, shared a post on X…
Oct 20, 2024, 10:56 | Insight
Guillermo Villacampa: The safety and efficacy of ADCs with immunotherapy
Guillermo Villacampa, Biostatistician, Vall d´Hebron Institute of Oncology (VHIO), shared a post on X: "Antibody-drug conjugate…
Oct 14, 2024, 17:03 | Blog
Guiding oncologists in aggressive cancer treatments: App by Vall d'Herbon
Oriol Mirallas, Medical Oncology Specialist at Vall d’Hebron Institute of Oncology, shared a post by Vall d'Hebron, on X,…
Sep 1, 2024, 15:26 | Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Jul 29, 2024, 11:19 | Insight
Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer
Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…
Jul 22, 2024, 20:26 | Insight
How tumor biology impacts Patritumab deruxtecan's efficacy in early breast cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, posted on X: "Our colleague Aleix Prat's…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
Jul 5, 2024, 06:54 | Blog
Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication
Paolo Tarantino, posted on X: "Nearly 1000 downloads in less than a week for our…
Jul 3, 2024, 12:06 | Insight
Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes
ESMO shared on LinkedIn: "For ESMO members: Breaking Science in breast cancer. Guillermo Villacampa presents…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
May 18, 2024, 08:31 | Opinion
Guillermo Villacampa: Marleen Kok presents the ESMO Breast 24 key message in translation research
Paolo Tarantino shared the following post by Guillermo Villacampa, Biostatistician in the Oncology Data Science…
All: 14 Posts: 1 - 100
Special Coverage